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Topographical Evaluation of Skin Perfusion Patterns in Peripheral 
Arterial Occlusive Disease by Means of Computer-assisted 
Fluorescein Perfusography 
Andreas Scheffler and Horst Rieger 
Aggertalklinik, Clinic for Vascular Diseases, W-51766 Engelskirchen, Federal Republic of Germany. 
Objective- To evaluate the clinical impact of computer-assisted fluorescein perfusography in peripheral arterial occlusive 
disease (PAOD). 
Design: Foot and calf skin peffusion was visualised by intravenous fluorescein injection. Fluorescein influx was recorded 
photographically and converted into functional images of fluorescein appearance times (AT) by means of digital film 
processing. 
Setting" Vascular Laboratory of Clinic for Vascular Disease. 
Materials" 249 patients with PAOD. Among 481 limbs studied, 83 legs presented with patent arteries, 70 with 
asymptomatic obstructions (Stage I), 170 with claudication (Stage II) and 158 with rest pain and skin lesions (Stage III/ 
IV). 
Chief outcome measures: Forefoot and calf mean ATs and standard deviations (SD) served as arbitrary measures of 
regional skin perfusion rates and their homogeneity, respectively. 
Main results: In the control legs, a homogeneous and fast fluorescence appearance was observed (medians at the foot: 
AT33.4 s, SD 3.6). In stage II disease, AT (39.9 s, SD 5.6) were slightly impaired as compared to limbs with patent arteries 
or stage I disease (p < 0.01). Ninety-seven out of the 158 legs in stage Ill~IV could be managed by conservative therapy. 
According to fluorescein-perfusography, t ey did not differ from stage II disease (AT 38.8 s, SD 6.1). Sixty-one limbs were 
clinically affected by critical ischaemia. They exhibited a markedly delayed and heterogenous fluorescein influx at the foot 
(AT 77.3 s, SD 26.5, p < 0.01 vs all other groups). Non-fluorescent areas occurred in 53% compared to only 1% of limbs 
with and without critical ischaemia, respectively. Retrospectively, predictive values of fluorescein perfusography in 
identifying a critical limb ischaemia (accuracy 93%) were superior to the ankle systolic arterial pressure determination 
(accuracy 80%). 
Conclusions: Fluorescein perfusography seems to be of diagnostic and prognostic use in PAOD in stage Ill~IV where 
inflammatory and ischaemic patterns of dye appearance can be distinguished. 
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Introduction 
Patients with peripheral arterial occlusive disease 
(PAOD) develop rest pain and ischaemic tissue necro- 
sis when the skin perfusion drops below a critical 
level. 1 Conventional vascular laboratory techniques 
do not provide insight into the actual degree and, 
particularl~ the spatial distribution of this cutaneous 
malcirculation. Thus microcirculatory methods have 
been used to assess ischaemic limb viability. 1-4 Tech- 
niques such as transcutaneous oxymetry of capillary 
microscopy, however, only measure local skin blood 
flow. In clinical practice, they require either a scanning 
Please address all correspondence to: Andreas Scheffier, Aggertalkli- 
nik, W-51766 Engelskirchen, Federal Republic of Germany. 
or simultaneous measurement at several probe posi- 
tions. 5 An alternative approach as been founded on 
the two-dimensional visualisation of the skin perfu- 
sion by means of an intravenous sodium-fluorescein 
injection. In PAOD patients this was introduced by 
Lange and Boyd 6 and has subsequently been taken up 
by several investigators. 7-1° Skin fluorescence was 
generally examined either by visual assessment under 
ultraviolet illumination in a darkened room or by 
photographs. Dermofluorometers were developed in 
order to quantify tissue fluorescence in vivo at certain 
sites. ~'~2 Substantial technical progress was achieved 
by recording the fluorescein i flux by means of rapid 
sequence photography (dynamic fluorescein angiog- 
raphy) 13 because fluorescence time-intensity curves 
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Table 1. Clinical data of 481 legs investigated 
ABI t  Angiography:~ Single 
Group / subgroup n (SD) (%) Level 
Occlusion sites (%)§ 
Multi-level 
no CA with CA 
Patent arteries 83 1.08 44.6 
(0.09) 
Asymptomatic 70 0.97 72.9 94.3 
Stage I (0.14) 
Intermittent claudication 170 0.55 76.5 58.9 
Stage II (0.17) 
Complicated limb ischaemia 158 0.39 88.6 32.9 
All cases in (31/127) (0.31) 
stage III/IV 
hnproved by 97 0.52 83.5 46.4 
conservative therapy* (0.31) 
Critical ischaemia*** 61 0.20 96.7 11.5 
(0.17) 
5.7 
15.3 25.8 
5.7 60.8 
1.0 51.6 
13.1 75.4 
systolic ankle arterial pressure 
t ABI (ankle brachial index) = :~ Angiography =percentage of limbs with actual arteriography. 
systolic brachial arterial pressure 
§ CA = calf arteries. 
* Occlusion sites p < 0.001 vs stage II (x~test). 
** Occlusion sites p < 0.001 vs Conservative Therapy (x2-test). 
could now be derived for various regions of interest 
from the film material by manual densitometry. 14 
Furthermore, in order to illustrate the instantaneous 
spatial skin perfusion distribution, the process of dye 
delivery can be converted into functional images by 
means of digital picture analysis. ~s'~6 
Until now, macroscopic fluorescein influx dynam- 
ics have been investigated on the plantar surface of 
patients with PAOD. 3'17-19 At the calf, static fluores- 
cence ~atterns or intensities have mainly been 
8-10 20--22 used. ' Therefore, in the present study, dynamic 
parameters of fluorescein delivery to the forefoot and 
calf of atherosclerotic limbs were analysed by means 
of digital image processing. We investigated how 
fluorescein appearance times and their regional varia- 
bility were influenced by: (1) clinical PAOD stages; (2) 
haemodynamic compensation; (3) patency of the calf 
arteries. Furthermore, the practical impact of fluor- 
escein perfusography in assessing critical imb ischae- 
mia was evaluated. 
Methods 
Patients 
Two hundred and forty nine in-patients aged 27 to 81 
years (mean 53 years) were examined by means of 
fluorescein perfusography during their routine vas- 
cular laboratory work-up. All patients presented with 
a PAOD of the lower extremities. The diagnosis was 
established on the basis of symptoms, pulse state, 
auscultation, ankle arterial pressures, multi-segmental 
oscillograph)~ colour-coded Duplex sonograph35 and 
angiography. 
A total of 481 legs were separated into five groups 
according to the common Fontaine staging 7(Table 1). 
Occlusion site levels were classified with respect o the 
iliac arter~ the femoropopliteal rter)5 and the calf 
arteries diagnosed either by angiography or colour- 
coded Duplex sonography. Seventeen patients had 
previously undergone lower leg amputation. One 
hundred and fifty-eight limbs presenting with rest 
pain or skin lesions at the time of fluorescein perfusog- 
raphy (stage III/IV) were retrospectively differen- 
tiated according to their clinical outcome with con- 
servative treatment for 3 weeks to 7 months (median 
11 weeks). Ninety-seven of them improved on stan- 
dard pharmacological measures 1 and local wound 
care. In the remaining 61 limbs (critical imb ischaemia 
group) conservative therapy failed and 31 surgical 
revascularisations (5 aortoiliac, 7 femoropopliteal, 18 
femorocrural) and 30 amputations (17 below-knee and 
13 minor amputations) were necessary. 
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Computer-assisted fluorescein perfusography 
All subjects gave their informed consent. Patients 
rested on an examination couch in supine position for 
1 hour at a constant room temperature of 29-31°C. In 
order to avoid side effects, 10 mg of clemastine was 
given intravenously. Fifteen rain later, the room was 
darkened and a baseline picture was taken. Then 10 
mg/kg body weight of sodium-fluorescein was rap- 
idly injected into a cubital vein through a 19-G-butter- 
fly needle followed by 10 ml of physiological saline 
solution. The fluorescein influx into the skin of both 
forefeet and calves was recorded by means of 
sequence photography over 3 rain. The motor-driven 
camera was electronically triggered every 2, 5 and 10 s 
during the first, second and third minutes, respec- 
tively. An annular ring flash equipped with a blue 
excitation filter served for illumination. A yellow- 
orange barrier filter was placed in front of the camera 
• • 14  objective. Subsequently, by means of a digital image 
processing system, 16 fluorescence appearance times, 
(AT), were calculated for each pixel of the investigated 
skin areas. Their topographical distribution was then 
displayed as an AT functional image in pseudocolours 
on a video screen (Fig. 4) and documented on polaroid 
film. Briefly, the negative film was transferred into a 
computer by means of a video camera and a video 
A/D-converter (512 × 512 matrix, 256 grey levels). An 
additionally photographed fluorescein dilution set 
allowed for correction of phototechnical variations. 
The baseline picture was subtracted from each picture 
taken after fluorescein injection in order to obtain the 
corresponding fluorescence intensity changes. The AT 
of a pixel was set to the time delay that had passed 
from the beginning of dye injection until the pixel's 
fluorescence intensity difference had exceeded a pre- 
viously defined threshold. 16 Regions of interest sepa- 
rately enclosing either forefoot and calf served to 
compute mean ATs and their standard eviations (SD) 
from the AT functional image. Furthermore, the AT 
functional image was scanned for non-fluorescent 
areas. 
Systolic arterial pressures at the ankle and arm 
were measured by means of an ultrasonic flow 
detector and a sphygmomanometric cuff with the 
patient positioned horizontally. Dividing the ankle by 
the arm value yielded the systolic arterial pressure 
ankle-to-brachial index (ABI). 
Statistical evaluation of fluorescein perfusographic data 
For all clinical groups, median values as well as 10th 
and 90th percentiles of AT and SD were derived from 
the corresponding frequency distributions. The Kol- 
mogoroff-Smirnoff test served for statistical 
comparison. 
Correlations between either AT or SD and the ABI 
were analysed by means of Spearman's coefficient of 
rank correlation, r s. 
In order to evaluate the infuence of calf artery 
obstructions, limbs with all calf arteries patent were 
compared to those with at least one run-off vessel 
obstructed. Groups of legs with similar ABI values 
were then compared by means of the Mann-Whitney- 
Wilcoxon U-test. 
Sensitivity (Sen), Specificity (Spe), positive and 
negative predictive values (PV +, PV-), and accuracy 
(Acc) were estimated using standard formulas. 23 
These test characteristics were applied to evaluate the 
ability of AT and SD to distinguish the 61 legs with 
critical limb ischaemia from the remaining 420. 
Results 
Severe fluorescein-induced anaphylactic complica- 
tions were not observed. Five patients (2%) com- 
plained of temporary nausea not requiring further 
treatment. One patient sustained a circumscribed 
phototoxical forearm skin reaction due to sun expo- 
sure which remitted after systemic corticoid 
administration. 
Fontaine PAOD stages 
Median values and ranges of ATs and SDs are listed in 
Tables 2 and 3, respectively. Figure 1 illustrates the 
corresponding AT frequency distributions of legs with 
patent arteries, intermittent claudication (stage II), 
(stage III/W) PAOD that improved on conservative 
therapy and critical limb ischaemia. SD histograms 
were of similar shape (not shown). Except for the 
limbs with critical ischaemia, homogeneous AT and 
SD distributions with a positive skewness were 
observed at the forefoot and calf. No differences were 
found between legs with patent arteries and those 
with asymptomatic obstructions (stage I). 
Intermittent claudication limbs exhibited AT and 
SD frequency distributions which were broadened 
and shifted to the right. Despite a substantial overlap 
with the normal range, forefoot AT and SD were 
significantly increased. At the call significant differ- 
ences were found for the homogeneity parameter, SD, 
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Table 2. Fluorescence appearance times, AT, at the foot and calf 
given as median values and 10th and 90th percentiles (numbers of 
cases are listed in Table 1) 
Foot ATF(S ) Calf ATc(s )
Group / subgroup 10th-90th 10th-90th 
Patent arteries 33.4 44.6 
25.247.6 26.5-45.8 
Asymptomatic 34.4 35.4 
Stage I 25.0-50.4 26.1-51.7 
Intermittent daudication 39.9~: 38.8 
Stage II 30.7-59.1 28.9-54.9 
Complicated limb ischaemia 
All cases in 47.5t$ 38.0 
stage III/IV 28.6-90.5 25.9-59.8 
Improved by 38.8 36.0 
conservative therapy 26.7-59.6 25.3-52.8 
Critical ischaemia 77.3tz~* 42.5t 
44.4-131.4 26.3-74.7 
f p < 0.01 vs 'patent arteries'. 
:~ p < 0.01 vs 'intermittent claudication'. 
* p < 0.01 vs 'complicated limb ischaemia improved by conservative 
therapy'. 
Table 3. Standard deviations of fluorescence appearance times, 
SD, at the foot and calf given as median values and 10th and 90th 
percentiles (numbers of cases are listed in Table 1) 
Foot SDF(s) Calf SDc(s) 
Group/subgroup 10th-90th 10th-90th 
Patent arteries 3.6 4.0 
1.9~.8 2.6-8.0 
Asymptomatic 3.9 4.0 
Stage I 2.0-10.0 2.2-9.2 
Intermittent claudication Stage II 5.6t 5.1t 
3.0-14.0 2.8-12.1 
Complicated limb ischaemia 
AII cases in 
stage III/IV 
Improved by 
conservative therapy 
Critical ischaemia 
10.0t• 5.4f 
3.2-39.6 2.8-17.2 
6.1f 4.9 
2.7-17.0 2.5-11.9 
26.5t:~* 6.7f$* 
11.3-43.5 3.9-24.2 
t p < 0.01 vs 'patent arteries'. 
:~ p < 0.01 vs 'intermittent claudication'. 
* p < 0.01 vs 'complicated limb ischaemia improved by conservative 
therapy'. 
only. In 25 out of 27 patients (93%) with unilateral 
claudication, forefoot AT and SD were intraindivid- 
ually impaired in the diseased leg. 
Limbs with rest pain and ulcerations showed 
inhomogeneous multimodal AT and SD histograms if 
evaluated independently of their clinical outcome. At 
the forefoot, these distributions ignificantly differed 
from those of the patent arteries and intermittent 
claudication groups. At the calf, again, the fluorescein 
influx was mainly more heterogeneous. 
When limbs with stage III/IV disease that 
improved on conservative treatment were considered 
separately from those with critical ischaemia, remark- 
able differences were detected. Legs with pain relief 
and healing ulcers exhibited fluorescence perfuso- 
graphic patterns imilar to those in stage II disease. In 
contrast, rather heterogeneous and far right-shifted 
forefoot AT and SD histograms were observed in the 
critical ischaemia group which only slightly over- 
lapped with those of the other clinical stages. Calf AT 
25 - . 
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Fig. 1. Relative frequencies of foot and calf mean fluorescence 
appearance times (AT) in 83 legs with patent arteries, 170 legs with 
intermittent claudication, 97 legs in stage III/IV disease that 
improved on conservative treatment, and 61 legs with critical 
ischaemia. ([3) foot; (11) calf. 
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and, especially, SD histograms of the critical limb 
ischaemia group were flattened and shifted to the 
right. Among the patients with successfully treated 
stage III/IV disease and those with critical limb 
ischaemia, 21% (20 of 97) and 33% (20 of 61) were 
diabetics, respectively (p<0.05, % 2 test). A similar 
relationship was found in the subgroup of limbs with 
healing and non-healing ulcerations (20% vs 35%, 
p < 0.05, Z z test). Diabetic and non-diabetic patients did 
not differ in their stage-related fluorescence perfuso- 
graphic results. 
The static fluorescence light intensity of near 
healing skin lesions was frequently high and the dye 
usually appeared within 60 s (inflammatory pattern). 
In contrast, failure of conservative therapy was asso- 
ciated with an extremely delayed fluorescence (ischae- 
mic pattern). Non-fluorescent areas inside skin regions 
with apparently normal transparency were observed 
in 56% (34 of 61) of the limbs with critical ischaemia 
compared to only 1% (4 of 420) of the remaining legs 
(p < 0.001, Z 2 test). Typically, they appeared on ischae- 
mic toes and forefeet. According to the clinical 
impression spontaneous skin necrosis arose close to 
these regions if revascularisation was not feasible and 
amputation became necessary. No differences were 
observed between diabetic and non-diabetic patients. 
Critical limb ischaemia 
Receiver-operator characteristic curves (ROC) of iden- 
tiff ing a critical limb ischaemia by means of fluor- 
escein perfusography are shown in Fig. 2. AT and SD 
ROCs were retrospectively calculated on bases of the 
61 and 420 limbs with and without critical ischaemia, 
respectively. The AT showed favourable test proper- 
ties with a threshold of 65 s in both identifying a 
critical ischaemia (Sen 79, Spe 96, PV + 75, PV- 97, Acc 
94) and predicting wound healing (Sen 96, Spe 77, 
PV + 89, PV- 92, Acc 90). In stage IV, 81 of 91 limbs 
with an AT less than 65 s improved with conservative 
treatment compared to only 3 of 36 limbs with an AT 
greater than 65 s. Similar results were obtained for the 
SD if a threshold of 18 s was assumed (identifying a
critical ischaemia: Sen 74, Spe 96, PV + 74, PV- 96, Acc 
93 / predicting wound healing: Sen 92, Spe 77, PV + 
89, PV- 83, Acc 87). In stage IV, 77 out of 87 limbs with 
a SD less than 18 s responded to conservative meas- 
ures compared to only 7 out of 40 limbs with a SD 
greater than 18 s. 
Ankle arterial pressures and run-off 
Figure 3 illustrates the inverse relationships between 
either forefoot AT or SD and the corresponding ABI. 
The two correlations reached statistical significance. 
Individual measurements, however, exhibited a sub- 
stantial scatter especially at ABI values below 0.6. 
Compared to legs with patent calf arteries, a delayed 
and, particularly, more heterogeneous forefoot fluor- 
escein influx was recorded in legs with occluded run- 
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Fig. 2. Receiver-operator characteristic curves (ROC) of identifying 
a critical limb ischaemia by means of computer-assisted fluorescein 
perfusography. ROCs were retrospectively calculated for 61 with 
and 420 limbs without critical ischaemia, respectively. Values drawn 
next o the curves indicate corresponding AT and SD thresholds (in 
s). Best discriminatory properties ofAT and SD were obtained with 
65 s and 18 s cut-off points, respectively. 
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Fig. 3. Relationships between forefoot appearance times (top) and 
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readings, mean values are drawn for limbs with either patent or 
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brackets beneath t e abscissa. Vertical and horizontal bars indicate 
standard eviations. In limbs with obstructed calf arteries, AT and 
SD increases were more pronounced and became evident at higher 
pressure ratios. Spearman's coefficients of rank correlation, rs,refer 
to all individual data. 
off vessels at ankle arterial pressure ratios below 0.5. 
These differences were statistically significant at ABI 
values between 0.3 and 0.4 (p < 0.05, Mann-Whitney- 
Wilcoxon U-test). 
D i s c u s s i o n  
Fluorescein perfusography assesses plasma flow 
because the dye does not penetrate into red blood 
cells. 21 Due to the optical resolution in the present 
stud35 each pixel covers about 20 to 40 capillaries (1 
mm2/pixel). Assuming that plasma and erythrocyte 
transport do not widely differ inside such a tissue 
volume, mean fluorescein appearance times (AT) 
serve as a measure of average regional skin perfusion. 
Fluorescein passage also indicates the absence of 
extensive capillary blockage. In contrast o previous 
densitornetric evaluations of certain time-intensity 
curves, 12"14'17-19'21'22 AT standard eviations (SD) were 
also derived from the spatial AT pattern by means of 
digital image processing in order to characterise the 
homogeneity of regional blood flow. Compared to 
static fluorescence intensities, dye appearance times 
are potentially less sensitive to increased capillary 
permeability in chronic arterial insufficiency 22'26 as 
well as the fluorescein kinetics of compartmental 
uptake and elimination, z7
The assumption that ATs predominately depend 
on skin perfusion rates 17"1s is supported by experi- 
mental findings. First, ATs markedly vary with ambi- 
ent temperatures. 24 Second, ATs are inversely corre- 
lated with peripheral perfusion pressures especially in 
case of reduced thermoregulatory s mpathetic activ- 
ity 18 (Fig. 3). According to several observations, 
fluorescein perfusography accurately reflects nutri- 
tional skin perfusion. High magnification close-up 
photography has revealed that the fluorescein influx 
into the superficial capillaries is predominantly 
recorded 14 as would be expected ue to the optical 
properties of the skin at the involved wave lengths of 
480-540 nm. 25 Appearance times measured by either 
fluorescein perfusography 24 or capillary microscopy 26
at the forefoot of PAOD patients correspond satisfacto- 
rily. In the present population, the predictive meaning 
of fluorescein perfusography was not reduced in 
diabetics who may have a critical imb ischaemia even 
at an elevated non-nutritional skin blood flow) '2 
Furthermore, the increased trans-capillary dye diffu- 
sion in diabetic patients 26 did not influence the 
computer-derived AT which only measures the flow- 
dependent initial phase of dye delivery. 
An age relationship with AT and SD could not be 
demonstrated for the 83 limbs with patent arteries 
(range 33 to 74 yrs). AT and SD reference ranges 
(ambient emperature 30°C) were estimated at about 
50 and 8 sec, respectively (Fig. 1, Tables 1, 2). 
Intraindividual dayl-6to-day variabilities of AT and SD 
amounted to 15%. In limbs With patent arteries, 
interindividual variabilities of AT and SD were 34% 
and 68%, respectively (Tables 2,3). AT and SD were 
intraindividually increased by only 18% and 84%, 
respectively, in patients with unilateral claudication. 
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Altogether, PAOD in stage II disease could not be 
reliably detected by means of fluorescein perfusog- 
raphy. Accordingly, neither AT nor SD correlated with 
ankle arterial pressure indices above 0.7 (Fig. 3). 
Despite their normal overall resting blood supply, 
limbs with intermittent claudication exhibited an 
increased heterogeneity of forefoot skin perfusion. 
This moderately impaired microvascular flow dis- 
tribution, however, did not seem to be of major clinical 
importance because it also existed in limbs with 
complicated PAOD that improved on conservative 
therapy. Heterogeneous capillary flow patterns have 
recently been observed in claudicants also by means of 
intravital microscopy. 26'28 Other authors have been 
able to provoke patchy static fluorescence intensity 
profiles on the plantar surface in PAOD patients 18 by 
leg elevation. 
Limbs with pain relief and healing skin lesions 
did not differ from the intermittent claudication 
group. This corresponds tothe clinical experience that 
PAOD stage II can be advanced to stage III/IV disease 
by minor skin trauma. ~Although such a wound with 
restricted blood supply may heal rather slowly, its 
prognosis is substantially better than that of a truly 
ischaemic necrosis. In accordance, forefoot AT and SD 
of limbs with critical ischaemia markedly differed 
from the remaining ones including those with improv- 
ing complicated PAOD. Moreover, in legs with critical 
ischaemia, fluorescein i flux was significantly delayed 
at the forefoot compared to the calf. Lange and Boyd 
have previously observed emarcations of skin fluo- 
rescence in patients with acute arterial occlusions. 2~ 
Other investigators have reported that non-fluorescent 
regions on static photographs taken I min 1° or 10 min 8 
after fluorescein administration i dicate a poor prog- 
nosis. A lack of fluorescence is generally assumed to 
indicate a prenecrotic failure of perfusion 7'9'14 
although they cannot be considered if localised inside 
skin lesionsY In the present study non-fluorescent 
areas turned out to be highly specific but not sensitive 
enough to predict critical ischaemia. Additionally, 
computing AT functional images has frequently 
revealed steep gradients of AT in limbs with critical 
ischaemia (Fig. 4). 
Low ankle arterial pressure indices (ABI) were 
statistically associated with a delayed and heteroge- 
neous fluorescein influx. Limbs with diseased calf 
arteries and low ABI exhibited the most pronounced 
deterioration of forefoot skin perfusion (Fig. 3). Thus, 
the remarkable scatter of the corresponding correlo- 
grams was partially due to disease-related factors 
detected by fluorescein perfusography but not by 
ABI. 
In agreement with previous findings, 2'3 the ABI 
proved to be unreliable in case of a complicated 
PAOD. Assuming a recently suggested pressure 
threshold of 50 mmHg, 1the positive predictive value 
of identifying critical ischaemia reached only 57% (Sen 
71, Spe 88, PV- 93, Acc 85). The negative predictive 
value of forecasting wound healing was 63% (Sen 81, 
Fig. 4. Functional image of colour-coded fluorescence appearance times, AT (scale on the right in seconds), in a normotensive 56-year-old 
male smoker with multi-segmental PAOD in stage IV of the left leg (ankle arterial pressure 30 mmHg) and patent arteries of the right leg. 
Substantially delayed and heterogeneous foot fluorescence appearance as well as several non-fluorescent areas at the toes indicated critical 
limb ischaemia (foot AT 75.7 _+ 43.7s, calf AT 30.6 + 4.0 s). Gradients of fluorescein influx can be detected at the ankle, the dorsum of the foot, 
and next to the toes. (Right leg: foot AT 25.2 +_ 1.7 s, calf AT 25.6 + 2.3 s). 
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Spe 63, PV + 81, Acc 75). Regarding its diagnostic and 
prognostic abilities in limbs with complicated PAOD, 
fluorescein perfusography was substantially better 
than ABI (Fig. 2). Predictive values are comparable to 
those reported for other techniques which assess 
nutritional skin perfusion, e.g. transcutaneous oxy- 
metry 4or capillary microscopy. 2 Under similar condi- 
tions, AT thresholds of 45 s 29 and 120 S 17 have been 
determined for the plantar surface. Predictive charac- 
teristics that can be calculated from such previously 
published plantar AT 17 for the 65 s cut-off point (Sen 
100, Spe 89, PV + 73, PV- 100, Acc 92) correspond with 
the findings presented here. Other authors have 
reported reliable forecasting of wound healing by 
means of plantar fluorescein angiography in a large 
diabetic population. 19 Furthermore, this study sup- 
ports a recent report where microcirculatory flow 
patterns in critical limb ischaemia were similar in 
diabetic and non-diabetic patients. B°
In summar~ computer-assisted fluorescein perfu- 
sography seems to be of clinical impact in patients 
with rest pain and skin ulcerations because it is 
relatively safe and permits two-dimensional scanning 
of skin blood supply. Two major fluorescein perfuso- 
graphic patterns can be distinguished in PAOD limbs 
with skin lesions: 
(1) The inflammatory pattern is characterised by 
normal dye appearance times and an intensified static 
ulcer fluorescence due to increased capillary permea- 
bility. Usually it is found in complicated stage II 
disease and responds to conservative treatment. 
(2) The ischaemic pattern exhibits an extremely 
delayed or even missing fluorochrome appearance. 
According to the present findings it seems to indicate 
the need for either evascularisation r amputation. 
The applicability of fluorescein perfusography in 
selecting amputation levels or recruiting patients for 
clinical trials in PAOD stage III/W disease remains to 
be investigated. Fluorescein perfusography does not 
compete with already established techniques such as, 
for example, transcutaneous oxymetry or capillary 
microscop3~ but may be advantageously combined 
with them, i.e. AT functional images can map islands 
of ischaemia for transcutaneous oxygen tension meas- 
urements or capillary visualisation. To enhance its 
routine use, digital video fluorescein perfusography 31 
has recently been introduced and is presently under 
clinical evaluation. 
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